Mid-Year Report

PODESTA GROUP, INC. for NOVO NORDISK INC

Firm
Client
Income
$100,000
Expenses
—

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion H. Con. Res. 99, Budget Resolution, Medicare/Medicaid provisions S. Con. Res. 21, Budget Resolution, Medicare/Medicaid provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion Possible DRA technical language H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions

LobbyistCovered position, as disclosed
TEAL BAKER —
PAUL BRATHWAITE EXEC DIR, CONGRESSIONAL BLACK CAUCUS 22 MEM
SHARON COHEN N/A
RANDALL GERARD N/A
ANDREW KAUDERS SR ADV, SEN. MENENDEZ; ED, HOUSE DEM CAUCUS
ELIZABETH ANN MORRA N/A
SETH NICHOLS N/A
ANTHONY PODESTA N/A
ANNE MARIE POLAK LEG CORRESPONDENT FOR CONG. MIKE FERGUSON
JEN SICILIANO —

Contacted: Executive Office of the President (EOP); Natl Institutes of Health (NIH); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Bills named: H.R. 4 (110th), H.Con.Res. 99 (110th), S. 3 (110th), H.R. 3162 (110th), S.Con.Res. 21 (110th), H.R. 2606 (110th), S. 1376 (110th)

Budget/Appropriations BUD

S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, diabetes research funding H. R. 3043, Labor-HHS-Education and Related Agencies Appropriations Act, diabetes research funding S. 1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, drug importation/FDA provisions H. R. 3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, drug importation/FDA provisions H. R. 2638, Homeland Security Appropriations Act, drug importation provisions S. 1644, Homeland Security Appropriations Act, drug importation provisions H. Con. Res. 99, Budget Resolution, Medicare/Medicaid, drug importation, and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, Medicare/Medicaid, drug importation, and comparative effectiveness provisions

LobbyistCovered position, as disclosed
TEAL BAKER —
PAUL BRATHWAITE EXEC DIR, CONGRESSIONAL BLACK CAUCUS 22 MEM
SHARON COHEN N/A
RANDALL GERARD N/A
ANDREW KAUDERS SR ADV, SEN. MENENDEZ; ED, HOUSE DEM CAUCUS
ELIZABETH ANN MORRA N/A
SETH NICHOLS N/A
ANTHONY PODESTA N/A
ANNE MARIE POLAK LEG CORRESPONDENT FOR CONG. MIKE FERGUSON
JEN SICILIANO —

Contacted: Food & Drug Administration (FDA); SENATE; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 1859 (110th), S.Con.Res. 21 (110th), S. 1644 (110th), H.Con.Res. 99 (110th), H.R. 2638 (110th), S. 1710 (110th), H.R. 3043 (110th), H.R. 3161 (110th)

Pharmacy PHA

H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions S. 1745, Commerce, Justice, Science and Related Agencies Appropriations Act, DEA drug importation language H. R. 2638, Homeland Security Appropriations Act, drug importation provisions S. 1644, Homeland Security Appropriations Act, drug importation provisions S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 623, Access to Life-Saving Medicine Act, follow-on biologics

LobbyistCovered position, as disclosed
TEAL BAKER —
PAUL BRATHWAITE EXEC DIR, CONGRESSIONAL BLACK CAUCUS 22 MEM
SHARON COHEN N/A
RANDALL GERARD N/A
ANDREW KAUDERS SR ADV, SEN. MENENDEZ; ED, HOUSE DEM CAUCUS
ELIZABETH ANN MORRA N/A
SETH NICHOLS N/A
ANTHONY PODESTA N/A
ANNE MARIE POLAK LEG CORRESPONDENT FOR CONG. MIKE FERGUSON
JEN SICILIANO —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Executive Office of the President (EOP); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS)

Bills named: S. 1745 (110th), S. 993 (110th), S. 1024 (110th), H.R. 1956 (110th), S.Con.Res. 21 (110th), S. 1082 (110th), S. 467 (110th), S. 484 (110th), S. 623 (110th), H.R. 1561 (110th), S. 1505 (110th), S. 596 (110th), S. 1644 (110th), H.R. 1038 (110th), H.Con.Res. 99 (110th), S. 1156 (110th), H.R. 2638 (110th), S. 1695 (110th), S. 242 (110th), H.R. 2900 (110th)

Medical/Disease Research/Clinical Labs MED

S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, diabetes research funding H. R. 3043, Labor-HHS-Education and Related Agencies Appropriations Act, diabetes research funding

LobbyistCovered position, as disclosed
TEAL BAKER —
PAUL BRATHWAITE EXEC DIR, CONGRESSIONAL BLACK CAUCUS 22 MEM
SHARON COHEN N/A
RANDALL GERARD N/A
ANDREW KAUDERS SR ADV, SEN. MENENDEZ; ED, HOUSE DEM CAUCUS
ELIZABETH ANN MORRA N/A
SETH NICHOLS N/A
ANTHONY PODESTA N/A
ANNE MARIE POLAK LEG CORRESPONDENT FOR CONG. MIKE FERGUSON
JEN SICILIANO —

Contacted: Executive Office of the President (EOP); Natl Institutes of Health (NIH); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 1710 (110th), H.R. 3043 (110th)

Health Issues HCR

LobbyistCovered position, as disclosed
TEAL BAKER —
PAUL BRATHWAITE EXEC DIR, CONGRESSIONAL BLACK CAUCUS 22 MEM
SHARON COHEN N/A
RANDALL GERARD N/A
ANDREW KAUDERS SR ADV, SEN. MENENDEZ; ED, HOUSE DEM CAUCUS
ELIZABETH ANN MORRA N/A
SETH NICHOLS N/A
ANTHONY PODESTA N/A
ANNE MARIE POLAK LEG CORRESPONDENT FOR CONG. MIKE FERGUSON
JEN SICILIANO —

Contacted: Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

S. 1145, Patent Reform Act of 2007, entire bill H R. 1908, Patent Reform Act of 2007, entire bill

LobbyistCovered position, as disclosed
TEAL BAKER —
PAUL BRATHWAITE EXEC DIR, CONGRESSIONAL BLACK CAUCUS 22 MEM
SHARON COHEN N/A
RANDALL GERARD N/A
ANDREW KAUDERS SR ADV, SEN. MENENDEZ; ED, HOUSE DEM CAUCUS
ELIZABETH ANN MORRA N/A
SETH NICHOLS N/A
ANTHONY PODESTA N/A
ANNE MARIE POLAK LEG CORRESPONDENT FOR CONG. MIKE FERGUSON
JEN SICILIANO —

Contacted: Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); SENATE; Food & Drug Administration (FDA)

Bills named: H.R. 1908 (110th), S. 1145 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.